Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Chemical Science
|
July 8, 2022
Zn(ii)-Coordination-driven self-assembled nanoagents for multimodal imaging-guided photothermal/gene synergistic therapy
Hui Hu, Nan Yang, Jiahui Sun, et al.
Journal of the American Chemical Society
|
April 25, 2025
Iodine-Induced Redirection of Active Sources in Cu-Based Catalysts during Efficient and Stable Water Oxidation
Mingzheng Gu, Ling Jiang, Hao Wang, et al.
Advanced Healthcare Materials
|
January 10, 2024
Orthogonally Sequential Activation of Self-Powered DNAzymes Cascade for Reliable Monitoring of mRNA in Living Cells
Fuqiang Zhang, Nan Yang, Fu Zhou, et al.
Analytical Chemistry
|
February 27, 2025
Aptamer-Induced Spatially Confined Electron Donors Enable Bi<sub>2</sub>S<sub>3</sub>/ZnIn<sub>2</sub>S<sub>4</sub> Heterostructures for Attomolar Photoelectrochemical Detection of Antibiotic Resistance Genes
Ruonan Qiao, Fu Zhou, Yinbo Ban, et al.
Oncology Research
|
February 26, 2020
A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma
Qiuyun Luo, Wentao Pan, Suna Zhou, et al.
Nature Communications
|
January 11, 2024
Self-propelled assembly of nanoparticles with self-catalytic regulation for tumour-specific imaging and therapy
Mengmeng Xia, Qiyue Wang, Yamin Liu, et al.
BMC Cancer
|
July 12, 2022
Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models
Douglas D Fang, Ran Tao, Guangfeng Wang, et al.
Cell & Bioscience
|
November 2, 2019
Preclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors
Xuechao Liu, Guangfeng Wang, Xianglei Yan, et al.
Journal of Medicinal Chemistry
|
March 25, 2017
Discovery of 4-((3'R,4'S,5'R)-6″-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2″-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3″-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development
Angelo Aguilar, Jianfeng Lu, Liu Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2025
MTA-Cooperative PRMT5 Inhibitors are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
Xiaochun Zhang, Dana C Borcherding, Minjie Zhang, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Chemical Science
|
July 8, 2022
Zn(ii)-Coordination-driven self-assembled nanoagents for multimodal imaging-guided photothermal/gene synergistic therapy
Hui Hu, Nan Yang, Jiahui Sun, et al.
Journal of the American Chemical Society
|
April 25, 2025
Iodine-Induced Redirection of Active Sources in Cu-Based Catalysts during Efficient and Stable Water Oxidation
Mingzheng Gu, Ling Jiang, Hao Wang, et al.
Advanced Healthcare Materials
|
January 10, 2024
Orthogonally Sequential Activation of Self-Powered DNAzymes Cascade for Reliable Monitoring of mRNA in Living Cells
Fuqiang Zhang, Nan Yang, Fu Zhou, et al.
Analytical Chemistry
|
February 27, 2025
Aptamer-Induced Spatially Confined Electron Donors Enable Bi<sub>2</sub>S<sub>3</sub>/ZnIn<sub>2</sub>S<sub>4</sub> Heterostructures for Attomolar Photoelectrochemical Detection of Antibiotic Resistance Genes
Ruonan Qiao, Fu Zhou, Yinbo Ban, et al.
Oncology Research
|
February 26, 2020
A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma
Qiuyun Luo, Wentao Pan, Suna Zhou, et al.
Nature Communications
|
January 11, 2024
Self-propelled assembly of nanoparticles with self-catalytic regulation for tumour-specific imaging and therapy
Mengmeng Xia, Qiyue Wang, Yamin Liu, et al.
BMC Cancer
|
July 12, 2022
Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models
Douglas D Fang, Ran Tao, Guangfeng Wang, et al.
Cell & Bioscience
|
November 2, 2019
Preclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors
Xuechao Liu, Guangfeng Wang, Xianglei Yan, et al.
Journal of Medicinal Chemistry
|
March 25, 2017
Discovery of 4-((3'R,4'S,5'R)-6″-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2″-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3″-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development
Angelo Aguilar, Jianfeng Lu, Liu Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2025
MTA-Cooperative PRMT5 Inhibitors are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
Xiaochun Zhang, Dana C Borcherding, Minjie Zhang, et al.
Page
of 10